Intact Genomics is a biotech company providing high-performance life science products and genomic services, including enzymes, competent cells, and proprietary technologies for DNA/RNA amplification, gene editing, and cloning.
Intact Genomics is an ISO 13485:2016 certified biotechnology company that specializes in the development and manufacture of high-performance molecular biology reagents and genomic services. Founded in 2013 and based in St. Louis, Missouri, the company leverages proprietary technologies, including Fungal Artificial Chromosomes (FAC) and advanced large DNA fragment cloning, to provide solutions for isothermal DNA/RNA amplification, gene editing, and molecular cloning. Their product portfolio, which includes over 100 items such as high-efficiency competent cells, enzymes, and RPA optimization tools, is designed to support high-quality, reproducible research across diverse fields including human health, agriculture, and environmental science.
The company serves a global customer base across academia and industry, enabling researchers to address complex challenges in genomic structure, function, and natural product discovery. By offering both off-the-shelf molecular biology products and custom services—such as library construction, protein expression, and OEM manufacturing—Intact Genomics provides scalable support for diagnostic development and drug discovery efforts. Their commitment to reliability and innovation has established them as a key resource for laboratories seeking specialized tools for streamlined cloning and rapid isothermal testing methods.